Sami Corwin

uniQure N.V. (NASDAQ:QURE) stock is trading lower on Thursday. • QURE shares are retreating from recent levels. Check the market position here. The gene therapy company received final meeting minutes from the U.S. Food and Drug Administration regarding a pre-Biologics License Application (BLA)...

Earlier this week, Sarepta Therapeutics, Inc (NASDAQ:SRPT) provided a safety update regarding Elevidys (delandistrogene moxeparvovec-rokl), the only approved gene therapy for patients with Duchenne muscular dystrophy, and steps the company is taking to strengthen the safety profile in non-...